First Interim Safety Analysis of a Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant

d'Amore, Francesco and da Silva, Maria Gomes and Leppa, Sirpa and Relander, Thomas and Pezzutto, Antonio and Lauritzsen, Grete F. and Weidmann, Eckhart and Van Gelder, Michel and Merup, Mats and Hagberg, Hans and Fagerli, Unn-Merete and Brown, Peter de Nully and Hansen, Per Boye and Mariz, Jose Mario and Jankovska, Milada and Walewski, Jan and Doorduijn, Jeanette and Van Hoof, Achiel and Christiansen, Ilse and Jyrkkio, Sirkku and Kluin-Nelemans, J. C. and Kooy, Marinus van Marwijk and Fijnheer, Rob and Stevens, Wendy and Zijlstra, Josee and Bohmer, L. and Lugtenburg, P. J. and Grube, Matthias and Prochazka, Vit and Salek, David and Greil, Richard and Trumper, Lorenz and Wulf, Gerald and Altmann, Bettina and Ziepert, Marita and Loeffler, Markus and Jantunen, Esa and Hopfinger, Georg and Van den Neste, Eric and Toldbod, Helle (2011) First Interim Safety Analysis of a Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant. BLOOD, 118 (21): 4110. p. 1755. ISSN 0006-4971

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 06 May 2020 09:35
Last Modified: 06 May 2020 09:35
URI: https://pred.uni-regensburg.de/id/eprint/19806

Actions (login required)

View Item View Item